OKYO Pharma News

Buy Rating Affirmed for OKYO Pharma on Promising Clinical Results of OK-101 for Neuropathic Corneal Pain

TipRanksJul 12 06:19 ET

OKYO Pharma Analyst Ratings

BenzingaJul 11 06:11 ET

OKYO Pharma Analyst Ratings

BenzingaMar 22 11:06 ET

Analysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and OKYO Pharma Limited Sponsored ADR (OKYO)

TipRanksMar 22 09:05 ET

Buy Rating Affirmed for OKYO Pharma Amid OK-101's Promising Phase 2 Results and Increased Approval Probability

TipRanksJan 8 08:25 ET

HC Wainwright & Co. Maintains Buy on OKYO Pharma, Raises Price Target to $5

BenzingaJan 8 08:17 ET

OKYO Pharma Analyst Ratings

BenzingaJan 8 08:17 ET

HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $4 Price Target

BenzingaDec 5, 2023 06:49 ET

OKYO Pharma Analyst Ratings

BenzingaDec 5, 2023 06:45 ET

HC Wainwright & Co. Initiates Coverage On OKYO Pharma With Buy Rating, Announces Price Target of $4

BenzingaNov 2, 2023 07:07 ET

OKYO Pharma Analyst Ratings

BenzingaNov 2, 2023 07:06 ET